ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,640, issued on July 8, was assigned to Max-Delbruck-Centrum fur Molekulare Medizin in der Helmholtz-Gemeinschaft (Berlin).

"Chimeric antigen receptor and CAR-T cells that bind BCMA" was invented by Armin Rehm (Berlin), Uta Elisabeth Hopken (Berlin), Julia Bluhm (Berlin), Wolfgang Uckert (Berlin), Elisa Kieback (Berlin) and Stephen Marino (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated chimeric antigen receptor polypeptide (CAR), wherein the CAR comprises an extracellular antigen-binding domain, comprising an antibody or antibody fragment that binds a B Cell Maturation Antigen (BCMA) polypeptide. The CAR preferably binds an epitope ...